Whose Responsibility is Research Reproducibility?
Tuesday, February 7, 2017 — 3:00 p.m. - 5:00 p.m.
Full conference registration is required to attend this session.
Associate Director, Catalyst & Associate Professor Therapeutics (AJ), University of California San Francisco
There is a broad consensus among academic and industry researchers, funders, and other stakeholders that increasing reproducibility of published research is an important goal. However, questions of who should be responsible for validating research results are tricky; industry and academia naturally diverge in answering these. Moreover, specific proposals for improving reproducibility are frequently contentious with fears of unintended consequences for the research enterprise. The goal of this panel is to have a conversation with both industry and academic perspectives on this challenging issue. This panel will be moderated by Richard Harris, the award-winning Science Correspondent for NPR.
Cathy Tralau-Stewart — Associate Director, Catalyst & Associate Professor Therapeutics (AJ), University of California San Francisco, San Francisco, CA, USA
Ivan Oransky — Co-Founder, Retraction Watch, New York, NY, USA
Veronique Kiermer — Executive Editor, PLOS, San Francisco, CA, USA
Elizabeth Iorns — Co-founder and CEO, Science Exchange, Palo Alto, CA, USA
Tara A. Schwetz — Senior Advisor to the Principal Deputy Director, NIH, National Institutes of Health, Bethesda, MD, USA
Richard Neve — Senior Research Scientist I, Gilead Sciences